7 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Thromboembolism Treatment ... Algorithm Branch ... @Clotmaster #Management ... #VTE #DVT #Algorithm ... #Hematology #Anticoagulation
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... #Anticoagulation ... #Management #Hematology ... #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... for VTE in Malignancy ... #Anticoagulation ... #Management #Hematology ... #Oncology
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline

First Line Treatment for HCC with Preserved
Clinical Practice Guideline ... First Line Treatment ... for Disease Progression ... #Management #Hepatology ... Gastroenterology #oncology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Thromboembolic Disease ... DeLoughery @Bloodman #VTE ... #anticoagulation ... #duration #management ... #length #treatment
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Valvular heart disease ... suggest prophylactic anticoagulation ... e.g., <50%), ESC guidelines ... Serial TTE and close ... #cardiology #treatment
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation